Working… Menu

A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01501799
Recruitment Status : Completed
First Posted : December 29, 2011
Last Update Posted : December 29, 2011
Information provided by (Responsible Party):
Actavis Mid-Atlantic LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2011
Actual Study Completion Date : December 2011